Cure First

Our organization is currently doing groundbreaking research that will revolutionize the way the medical industry treats and cures cancer without the use of chemotherapy or radiation. By utilizing unique functional genomics, robotics instruments, computational tools, and high-throughput screening methods, Cure First can change the world! Our research team is currently conducting research projects onnew drug combinations for ovarian cancer and neuroblastoma. We are also focusing on four of the most the aggressive subtypes of cancer - head and neck squamous cell carncinoma, pancreatic ductal adenocarcinoma, and triple-negative breast cancer. With success in the clinical trials of treating and curing two of these cancers that previously had no known treatment or therapies, we’re hopeful for what the future has in store! There are plans to expand screening into ovarian and childhood cancer types that are also in the works. We've had significant success thus far in utilizing novel drugs to treat and target carcinomic genomes. Cure First's research and applications have been found that targeting specific carcinomic genomes leads not only to tumor regression in preclinical models, but that health and life of non-carcinoma surrounding cells can simultaneously be improved. We hope that you'll join us on our journey to finding a cure for cancer... You're helping us change the world. Together we can find a cure!